As more states restrict clinician-managed abortion in the wake of Dobbs v. Jackson Women’s Health Organization, the Supreme Court decision that overturned Roe v Wade in 2022, more patients are pursuing self-managed medication abortion (SMMA). Definitions of SMMA can vary, but SMMA typically refers to the use of mifepristone and/or misoprostol to induce abortion outside of a clinical context. Despite the 97% completion rate and excellent safety record of a medication abortion, patients who pursue SMMA sometimes experience symptoms that prompt them to visit an emergency department or primary care clinic for evaluation.
This article was originally published on MedicalXpress.com
